CDC's Updated COVID-19 Vaccine Guidelines Unveiled

The U.S. CDC has issued guidance recommending a second dose of the 2024-2025 COVID-19 vaccine for individuals aged 65 and older, as well as for those who are moderately or severely immunocompromised. This guidance aims to enhance protection for these vulnerable groups in upcoming years.

The U.S. Centers for Disease Control and Prevention (CDC) has recommended a second dose of the 2024-2025 COVID-19 vaccine for individuals over the age of 65.

This guidance also applies to individuals who are moderately or severely immunocompromised, aiming to bolster their protection against the virus.

The decision comes as part of ongoing efforts to safeguard vulnerable populations, ensuring better community health outcomes as the pandemic continues to evolve.